BioNTech SE. (BNTX) NASDAQ
$86.40 0.06 (0.07%)
Market Cap: $20.53B
As of 04/17/24 04:00 PM EDT. Market closed.
BioNTech SE. (BNTX)
NASDAQ
$86.40
0.06 (0.07%)
Market Cap: $20.53B
As of 04/17/24 04:00 PM EDT. Market closed.
everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the ... read more
everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/ read less
Open in: 
Open in:
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 1,640,016 | 0.00441% | 4.21% | Other |
| CAPITAL WORLD INVESTORS | 938,747 | 0.02% | 1.52% | Growth At A Reasonable Price |
| BAMCO INC /NY/ | 242,348 | 0.07% | 52.51% | Growth At A Reasonable Price |
| D. E. SHAW & CO., INC. | 184,600 (Put) | 0.02% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 90,427 | 0.001% | 2.68% | Other |
| PLATINUM INVESTMENT MANAGEMENT LTD | 79,552 | 0.34% | 16.41% | Growth At A Reasonable Price, Value |
| D. E. SHAW & CO., INC. | 61,281 | 0.00565% | 47.4% | Other |
| CANDRIAM S.C.A. | 40,303 | 0.03% | -33.17% | Other |
| UBS OCONNOR LLC | 4,363 | 0.03% | 9.08% | Value |
| BRIDGEWATER ASSOCIATES, LP | 4,083 | 0.00241% | New | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 3,844 | 0.00201% | No change | Event Driven, Value |
Period of Report: 12/31/2023
10-K/10-Q Filings: View